Thorough Future
PrivateLast Round
Series A++
Sep 26, 2025
Total Funding Raised
$27.6M
Company Overview
Thorough Future operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series A++ round in September 2025.
Thorough Future is a healthtech company that develops an AI-driven pathology imaging platform to enhance diagnostic accuracy and efficiency for hospitals and laboratories.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thorough Future Comparables
Compare Thorough Future with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 玖壹叁陆零医学科技南京有限公司 | 87% | |
| PathoAI | 86% | |
| Qritive | 83% |
For institutional investors. Book with your work email.
Thorough Future Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A++ | Sep 26, 2025 | ||||
| Series A Extension | Jun 6, 2024 | ||||
| Series A | Jun 26, 2023 | ||||
| Angel | Jul 28, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Thorough Future Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Qianhai Bangqin Investment | Series A++, Series A Extension |
| Turing Ventures | Series A++, Angel |
| KIP Capital Management | Series A++, Angel, Series A Extension, Series A |
| Puhua Capital | Series A++, Angel |
| Hongdao Capital | Series A++, Angel |
| Panlin Capital | Series A++, Angel |
| Qiming Venture Partners | Series A++, Angel, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2025
Raised Series A++ with investors including Qiming Venture Partners and Hongdao Capital.
- Jun 6, 2024
$14M round led by Shenzhen Qianhai Bangqin Investment.
For institutional investors. Book with your work email.
Thorough Future Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Thorough Future's valuation, stock price, and market status.
Is Thorough Future a public or private company?
Thorough Future is a private company.
What is the current stock price of Thorough Future?
Thorough Future is a private company, so its shares have no public market price. Caplight tracks Thorough Future's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Thorough Future worth (valuation)?
Valuation information for Thorough Future is not publicly available.
Can I buy Thorough Future stock?
Thorough Future shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Thorough Future's last funding round?
Thorough Future's most recent funding round was Series A++ on September 26, 2025.
Who are the main investors in Thorough Future?
Key investors in Thorough Future include Shenzhen Qianhai Bangqin Investment, Qiming Venture Partners.
Will Thorough Future IPO soon?
No public IPO plans have been announced for Thorough Future.
How can I track Thorough Future secondary market activity?
Caplight tracks bids, offers, and trades in Thorough Future's shares on secondary markets.